Fewer dentist visits hit Invisalign maker Align last year. Here's why the stock is rallying now.
By Bill Peters
First-quarter, full-year forecasts top expectations
Shares of Align Technology Inc. jumped after hours Wednesday on an upbeat sales outlook, following an uptick in revenue for the company's Invisalign teeth-alignment system.
The company made that forecast after it expressed concerns about demand last year, after fewer patients went to the dentist and higher prices for basic essentials left them with less money to spend elsewhere. They also follow rival SmileDirectClub's announcement last month that it was closing up shop.
Align said it expected first-quarter sales of $960 million to $980 million, above the FactSet consensus forecast for $947 million. For the full year, the company expected sales to be "up mid-single digits" year over year, compared with FactSet expectations for around 4% growth.
Shares jumped 10.3% after hours.
Invisalign treatment involves a visit to the doctor, a 3-D scan of the patient's teeth, and clear aligners to help straighten them out. Align sells most of its products to orthodontists and dental labs, according to its annual report.
For its fourth quarter, Align reported $956.7 million in sales, up 6.1% year over year and above Wall Street's expectations for $934 million.
The company reported net income of $124 million, or $1.64 a share, up from $41.8 million, or $1.73 a share, in the same quarter that ended in 2022. Adjusted earnings per share were $2.42 for the quarter, above the consensus estimate of $2.18.
In a statement on Wednesday, Align Chief Executive Joe Hogan said the fourth-quarter results reflected greater Invisalign demand for adults and teens, and growth in Canada and Europe, the Middle East and Africa.
Sales for the company's clear teeth aligners were $781.9 million, up 6.9% year over year. However, shipments for those aligners during the quarter fell 0.6%.
In October, when Align Technology reported third-quarter results, Hogan had said that demand was lower than expected.
"Dental practices and industry research firms have reported deteriorating trends, including decreased patient visits and increased patient appointment cancellations, along with fewer orthodontic case starts overall, especially among adult patients," he said then.
The company on Wednesday also unveiled a new scanner that it said could more quickly and accurately capture the contours of the inside of someone's mouth.
Shares of Align are down 5.4% over the past 12 months.
-Bill Peters
This content was created by MarketWatch, which is operated by Dow Jones & Co. MarketWatch is published independently from Dow Jones Newswires and The Wall Street Journal.
(END) Dow Jones Newswires
01-31-24 1736ET
Copyright (c) 2024 Dow Jones & Company, Inc.-
These Stocks Are (Still) Powering the Bull Market
-
5 Undervalued Energy Stocks to Play the AI Data Center Demand Boom
-
After Earnings, Is Lowe’s Stock a Buy, Sell, or Fairly Valued?
-
5 Stocks With the Largest Fair Value Estimate Cuts After Q1 Earnings
-
10 Stocks With the Largest Fair Value Estimate Increases After Q1 Earnings
-
Markets Brief: Inflation Back in the Spotlight
-
AI Is Booming, but Consumer Spending Is Slowing. Which Will Prevail in the Stock Market?
-
What’s Happening In the Markets This Week
-
3 Dividend Stocks for June 2024
-
After Earnings, Is Alibaba Stock a Buy, Sell, or Fairly Valued?
-
MongoDB Earnings: Slashing Valuation as Execution and Macro to Blame for Lower Guidance
-
Marvell Earnings: We Raise Our Medium-Term AI Forecast and Bring Our Valuation Up to $75
-
Zscaler Earnings: Impressive Traction in Emerging Products Drives Sales Growth for the Quarter
-
Dell Earnings: Raising Valuation on Strong AI, but the Stock Remains Severely Overvalued
-
After Earnings, Is Nvidia Stock a Buy, Sell, or Fairly Valued?
-
The 10 Best Companies to Invest in Now